Nosocomial transmission of parainfluenza 3 virus in hematological patients characterized by molecular epidemiology

Transplant Infectious Disease

Volumn 13, Issue 4, 2011, Pages 433-437

  Lee, A V ^a   Bibby, D F ^a   Oakervee, H ^a   Rohatiner, A ^a   Ushiro Lumb, I ^a   Clark, D A ^a   Mattes, F M ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Immunocompromised; Molecular epidemiology; Nosocomial transmission; Parainfluenza; Viral infection

Indexed keywords

RIBAVIRIN;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; GENETIC STRAIN; HEALTH CARE PERSONNEL; HEMATOLOGY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; MOLECULAR EPIDEMIOLOGY; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; SAMPLE; SEQUENCE ANALYSIS; VIRUS TRANSMISSION; WARD;

AGED; CHILD; CROSS INFECTION; DISEASE OUTBREAKS; HEALTH PERSONNEL; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MOLECULAR EPIDEMIOLOGY; NEOPLASMS, GERM CELL AND EMBRYONAL; PARAINFLUENZA VIRUS 3, HUMAN; PHYLOGENY; RESPIRATORY TRACT INFECTIONS; RESPIROVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA;

EID: 79961208394     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00603.x     Document Type: Article

References (16)

1. Laurichesse H, Dedman D, Watson JM, Zambon MC. Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur J Epidemiol 1999; 15: 475-484.
2. Karron RA, O'Brien KL, Froehlich JL, Brown VA. Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward. J Infect Dis 1993; 167: 1441-1445.
3. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-1928.
4. Jalal H, Bibby DFB, Bennett J, et al. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J Clin Microbiol 2007; 45: 1690-1696.
5. Hohenthal U, Nikoskelainen J, Vainionpää R, et al. Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplant 2001; 27: 295-300.
6. Zambon M, Bull T, Sadler CJ, Goldman JM, Ward KN. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol 1998; 36: 2289-2293.
7. Cortez KJ, Erdman DD, Peret TCT. Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis 2001; 184: 1093-1097.
8. Folgueira L, Otero JR, Lizasoain M, Caltenco R, Delgado R. Parainfluenza 3 virus nosocomial outbreak in hematological patients. Intersci Conf Antimicrob Agents Chemother 2001; 41: (abstract K-1441).
9. Swierkosz EM, Erdman DD, Bonnot T, Schneiderheinze C, Waner JL. Isolation and characterization of a naturally occurring parainfluenza 3 virus variant. J Clin Microbiol 1995; 33: 1839-1841.
10. Marcolini JA, Malik S, Suki D, Whimbey E. Respiratory disease due to parainfluenza virus in adult leukemia patients. Eur J Clin Microbiol Infect Dis 2003; 22: 79-84.
11. Karron RA, Froehlich JL, Bobo L, Belshe RB, Yolken RH. Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay. J Clin Microbiol 1994; 32: 484-488.
12. van Wyke Coelingh KL, Winter CC, Murphy BR. Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983. Virology 1988; 162: 137-143.
13. Echevarría JE, Erdman DD, Meissner HC, Anderson L. Rapid molecular epidemiologic studies of human parainfluenza viruses based on direct sequencing of amplified DNA from a multiplex RT-PCR assay. J Virol Methods 2000; 88: 105-109.
14. Jeffries DJ. Viral hazards to and from health care workers. J Hosp Infect 1995; 30 (Suppl): 140-155.
15. Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003; 55: 83-91.
16. Nichols WG, Erdman DD, Han A, Zukerman C, Corey L, Boeckh M. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant 2004; 10: 58-64.